La Historia del Mapa del Mundo desde la Antigüedad (La Evolución de la Cartografía)
www.youtube.com/watch?v=VGi9...
www.youtube.com/watch?v=VGi9...
La Historia del Mapa del Mundo desde la Antigüedad (La Evolución de la Cartografía)
YouTube video by Via Doctis (Español)
www.youtube.com
April 23, 2026 at 6:35 AM
La Historia del Mapa del Mundo desde la Antigüedad (La Evolución de la Cartografía)
www.youtube.com/watch?v=VGi9...
www.youtube.com/watch?v=VGi9...
🌍 DoctisEU comes to an end, helping more patients with immune-mediated inflammatory diseases
🔬Proud partners of this EU-funded project, which achieved key milestones, from a promising therapeutic strategy to an innovative Clinical Trial
doctis.eu/doctis-outco...
#IMIDs #H2020 @hoheyn.bsky.social
🔬Proud partners of this EU-funded project, which achieved key milestones, from a promising therapeutic strategy to an innovative Clinical Trial
doctis.eu/doctis-outco...
#IMIDs #H2020 @hoheyn.bsky.social
July 6, 2026 at 7:15 AM
🌍 DoctisEU comes to an end, helping more patients with immune-mediated inflammatory diseases
🔬Proud partners of this EU-funded project, which achieved key milestones, from a promising therapeutic strategy to an innovative Clinical Trial
doctis.eu/doctis-outco...
#IMIDs #H2020 @hoheyn.bsky.social
🔬Proud partners of this EU-funded project, which achieved key milestones, from a promising therapeutic strategy to an innovative Clinical Trial
doctis.eu/doctis-outco...
#IMIDs #H2020 @hoheyn.bsky.social
🚨 Don't miss this interview with our Single Cell Genomics Group Leader, @hoheyn.bsky.social!
🔎Discover how the EU-funded project Doctis is advancing Immune-Mediated Inflammatory Diseases research, paving the way for personalised therapies
📎 doctis.eu/holger-heyn-...
#IMIDs #SingleCell #Genomics
🔎Discover how the EU-funded project Doctis is advancing Immune-Mediated Inflammatory Diseases research, paving the way for personalised therapies
📎 doctis.eu/holger-heyn-...
#IMIDs #SingleCell #Genomics
July 1, 2026 at 7:18 AM
🚨 Don't miss this interview with our Single Cell Genomics Group Leader, @hoheyn.bsky.social!
🔎Discover how the EU-funded project Doctis is advancing Immune-Mediated Inflammatory Diseases research, paving the way for personalised therapies
📎 doctis.eu/holger-heyn-...
#IMIDs #SingleCell #Genomics
🔎Discover how the EU-funded project Doctis is advancing Immune-Mediated Inflammatory Diseases research, paving the way for personalised therapies
📎 doctis.eu/holger-heyn-...
#IMIDs #SingleCell #Genomics
👀 Curious about what we’re doing in immune-mediated inflammatory diseases across Europe?
📹 Watch this presentation by our Single Cell Genomics Group Leader at CNAG, @hoheyn.bsky.social, under the umbrella of the DOCTIS Project ⬇️
📎 doctis.eu/relive-docti...
#IMIDResearch #AutoimmuneTherapies
📹 Watch this presentation by our Single Cell Genomics Group Leader at CNAG, @hoheyn.bsky.social, under the umbrella of the DOCTIS Project ⬇️
📎 doctis.eu/relive-docti...
#IMIDResearch #AutoimmuneTherapies
Relive the DocTIS webinar: "Discovery of combination therapies for Immune-Mediated Inflammatory Diseases" - Doctis
In February 2025, the DocTIS project hosted an insightful webinar during one of its General Assemblies, marking a key milestone as the initiative enters its
doctis.eu
February 20, 2026 at 8:41 AM
👀 Curious about what we’re doing in immune-mediated inflammatory diseases across Europe?
📹 Watch this presentation by our Single Cell Genomics Group Leader at CNAG, @hoheyn.bsky.social, under the umbrella of the DOCTIS Project ⬇️
📎 doctis.eu/relive-docti...
#IMIDResearch #AutoimmuneTherapies
📹 Watch this presentation by our Single Cell Genomics Group Leader at CNAG, @hoheyn.bsky.social, under the umbrella of the DOCTIS Project ⬇️
📎 doctis.eu/relive-docti...
#IMIDResearch #AutoimmuneTherapies
5️⃣ Next steps
Researchers are now working on standardising protocols and integrating the atlas into clinical practice.
A groundbreaking study led by Drs @hoheyn.bsky.social, @jcnietos.bsky.social, @dmaspero.bsky.social, @saguilarfer.bsky.social, & team, this effort is part of the EU-funded Doctis
Researchers are now working on standardising protocols and integrating the atlas into clinical practice.
A groundbreaking study led by Drs @hoheyn.bsky.social, @jcnietos.bsky.social, @dmaspero.bsky.social, @saguilarfer.bsky.social, & team, this effort is part of the EU-funded Doctis
January 12, 2026 at 10:22 AM
5️⃣ Next steps
Researchers are now working on standardising protocols and integrating the atlas into clinical practice.
A groundbreaking study led by Drs @hoheyn.bsky.social, @jcnietos.bsky.social, @dmaspero.bsky.social, @saguilarfer.bsky.social, & team, this effort is part of the EU-funded Doctis
Researchers are now working on standardising protocols and integrating the atlas into clinical practice.
A groundbreaking study led by Drs @hoheyn.bsky.social, @jcnietos.bsky.social, @dmaspero.bsky.social, @saguilarfer.bsky.social, & team, this effort is part of the EU-funded Doctis
👀 Did you miss the Doctis webinar?
You can now watch “Discovery of Combination Therapies for Immune-Mediated Inflammatory Diseases” online
As project partners, our Group Leader @hoheyn.bsky.social contributed to the discussion led by Sara Marsal (@vhir.bsky.social)
You can now watch “Discovery of Combination Therapies for Immune-Mediated Inflammatory Diseases” online
As project partners, our Group Leader @hoheyn.bsky.social contributed to the discussion led by Sara Marsal (@vhir.bsky.social)
DocTIS webinar: Discovery of combination therapies for Immune-Mediated Inflammatory Diseases
The DocTIS project (https://doctis.eu/) is a Horizon Europe-funded initiative that focuses on identifying more effective therapies for immune-mediated inflammatory diseases (IMIDs).
By leveraging…
www.youtube.com
November 27, 2025 at 3:07 PM
👀 Did you miss the Doctis webinar?
You can now watch “Discovery of Combination Therapies for Immune-Mediated Inflammatory Diseases” online
As project partners, our Group Leader @hoheyn.bsky.social contributed to the discussion led by Sara Marsal (@vhir.bsky.social)
You can now watch “Discovery of Combination Therapies for Immune-Mediated Inflammatory Diseases” online
As project partners, our Group Leader @hoheyn.bsky.social contributed to the discussion led by Sara Marsal (@vhir.bsky.social)
💙Today is #WorldArthritisDay, raising awareness of rheumatic and musculoskeletal diseases affecting millions worldwide
At CNAG, we support this cause through initiatives such as #DocTIS, developing new therapeutic strategies for immune-mediated inflammatory diseases
#RMDreams #WAD2025 #Arthritis
At CNAG, we support this cause through initiatives such as #DocTIS, developing new therapeutic strategies for immune-mediated inflammatory diseases
#RMDreams #WAD2025 #Arthritis
October 12, 2025 at 9:49 AM
💙Today is #WorldArthritisDay, raising awareness of rheumatic and musculoskeletal diseases affecting millions worldwide
At CNAG, we support this cause through initiatives such as #DocTIS, developing new therapeutic strategies for immune-mediated inflammatory diseases
#RMDreams #WAD2025 #Arthritis
At CNAG, we support this cause through initiatives such as #DocTIS, developing new therapeutic strategies for immune-mediated inflammatory diseases
#RMDreams #WAD2025 #Arthritis
📢#DocTIS will be at #IMMUNOLOGY2025!
🗣️Dr. Julià (@vhir.bsky.social) will present a collaborative study with CNAG & other partners: “Uncovering combination therapies for immune-mediated inflammatory diseases through systems biology analysis of longitudinal patient data"
doctis.eu/doctis-resea...
🗣️Dr. Julià (@vhir.bsky.social) will present a collaborative study with CNAG & other partners: “Uncovering combination therapies for immune-mediated inflammatory diseases through systems biology analysis of longitudinal patient data"
doctis.eu/doctis-resea...
DocTIS’ research to be presented at Immunology 2025
The annual meeting of the American Association of Immunologists is recognised as the world’s largest all-immunology event. Its 108th edition, Immunology 2025,
doctis.eu
May 2, 2025 at 8:04 AM
📢#DocTIS will be at #IMMUNOLOGY2025!
🗣️Dr. Julià (@vhir.bsky.social) will present a collaborative study with CNAG & other partners: “Uncovering combination therapies for immune-mediated inflammatory diseases through systems biology analysis of longitudinal patient data"
doctis.eu/doctis-resea...
🗣️Dr. Julià (@vhir.bsky.social) will present a collaborative study with CNAG & other partners: “Uncovering combination therapies for immune-mediated inflammatory diseases through systems biology analysis of longitudinal patient data"
doctis.eu/doctis-resea...
🌟Big step in #PrecisionMedicine: CNAG publishes an inflammation atlas with 6.5 million single cells from 1,047 patients across 19 diseases!
🎯Key to understanding inflammation in infections, autoimmune diseases & cancer
Led by @hoheyn.bsky.social, under Doctis Proj.
www.biorxiv.org/content/10.1...
🎯Key to understanding inflammation in infections, autoimmune diseases & cancer
Led by @hoheyn.bsky.social, under Doctis Proj.
www.biorxiv.org/content/10.1...
www.biorxiv.org
April 11, 2025 at 9:44 AM
🌟Big step in #PrecisionMedicine: CNAG publishes an inflammation atlas with 6.5 million single cells from 1,047 patients across 19 diseases!
🎯Key to understanding inflammation in infections, autoimmune diseases & cancer
Led by @hoheyn.bsky.social, under Doctis Proj.
www.biorxiv.org/content/10.1...
🎯Key to understanding inflammation in infections, autoimmune diseases & cancer
Led by @hoheyn.bsky.social, under Doctis Proj.
www.biorxiv.org/content/10.1...
🔎 Discover the latest advances in treatments for Immune-Mediated Inflammatory Diseases in the #DocTISProject #webinar
🗣️ Featuring @hoheyn.bsky.social, our Single Cell Genomics Group Leader, discussing molecular data generation from IMID Biobank patients
🔗 doctis.eu/relive-docti...
#IMID #CNAG
🗣️ Featuring @hoheyn.bsky.social, our Single Cell Genomics Group Leader, discussing molecular data generation from IMID Biobank patients
🔗 doctis.eu/relive-docti...
#IMID #CNAG
Relive the DocTIS webinar: "Discovery of combination therapies for Immune-Mediated Inflammatory Diseases" - Doctis
In February 2025, the DocTIS project hosted an insightful webinar during one of its General Assemblies, marking a key milestone as the initiative enters its
doctis.eu
March 21, 2025 at 10:08 AM
🔎 Discover the latest advances in treatments for Immune-Mediated Inflammatory Diseases in the #DocTISProject #webinar
🗣️ Featuring @hoheyn.bsky.social, our Single Cell Genomics Group Leader, discussing molecular data generation from IMID Biobank patients
🔗 doctis.eu/relive-docti...
#IMID #CNAG
🗣️ Featuring @hoheyn.bsky.social, our Single Cell Genomics Group Leader, discussing molecular data generation from IMID Biobank patients
🔗 doctis.eu/relive-docti...
#IMID #CNAG
Mi iscrissi a twitter nel 2016 . Lo trovavo stimolante per comprendere ed aggiornarmi. Poi il declino inesorabile. Al momento mi sembra di ritrovare su bluesky lo stesso spirito. Vedremo. Disce, sed a doctis, indoctos ipse doceto (Impara, ma da coloro che sanno, insegna a coloro che non sanno)
November 29, 2024 at 10:34 AM
Mi iscrissi a twitter nel 2016 . Lo trovavo stimolante per comprendere ed aggiornarmi. Poi il declino inesorabile. Al momento mi sembra di ritrovare su bluesky lo stesso spirito. Vedremo. Disce, sed a doctis, indoctos ipse doceto (Impara, ma da coloro che sanno, insegna a coloro che non sanno)
Navis ut est solitum maior quam aliae gravitate
Doctis cum nautis, nec sine duce bono.
Factis cum gregibus ferri pactis neque multis,
Sic Cojahogam plena petivit ope.
Doctis cum nautis, nec sine duce bono.
Factis cum gregibus ferri pactis neque multis,
Sic Cojahogam plena petivit ope.
November 15, 2025 at 10:00 PM
Navis ut est solitum maior quam aliae gravitate
Doctis cum nautis, nec sine duce bono.
Factis cum gregibus ferri pactis neque multis,
Sic Cojahogam plena petivit ope.
Doctis cum nautis, nec sine duce bono.
Factis cum gregibus ferri pactis neque multis,
Sic Cojahogam plena petivit ope.
Decision on Optimal Combinatorial Therapies in Immune-mediated inflammatory diseases using Systems approaches (DocTIS): protocol for a single-arm, adaptive basket trial in rheumatoid and psoriatic arthritis academic.oup.com/rheumap/arti... #hvhebron #reu [Text complet]
Decision on Optimal Combinatorial Therapies in Immune-mediated inflammatory diseases using Systems approaches (DocTIS): protocol for a single-arm, adaptive basket trial in rheumatoid and psoriatic art...
AbstractObjectives. Current treatments for rheumatoid arthritis (RA) and psoriatic arthritis (PsA) reduce disease activity but often fail to achieve sustai
academic.oup.com
May 8, 2026 at 2:33 PM
Decision on Optimal Combinatorial Therapies in Immune-mediated inflammatory diseases using Systems approaches (DocTIS): protocol for a single-arm, adaptive basket trial in rheumatoid and psoriatic arthritis academic.oup.com/rheumap/arti... #hvhebron #reu [Text complet]
ClassicsBluesky #Latin 🏺🧵
A quick spot of Catullus #WorldBookDay
“cui dono lepidum novum libellum
arido modo pumice expolitum?
Corneli, tibi: namque tu solebas
meas esse aliquid putare nugas,
iam tum cum ausus es unus Italorum
omne aevum tribus explicare chartis
doctis, Iuppiter, et laboriosis....
A quick spot of Catullus #WorldBookDay
“cui dono lepidum novum libellum
arido modo pumice expolitum?
Corneli, tibi: namque tu solebas
meas esse aliquid putare nugas,
iam tum cum ausus es unus Italorum
omne aevum tribus explicare chartis
doctis, Iuppiter, et laboriosis....
March 6, 2025 at 9:15 PM
ClassicsBluesky #Latin 🏺🧵
A quick spot of Catullus #WorldBookDay
“cui dono lepidum novum libellum
arido modo pumice expolitum?
Corneli, tibi: namque tu solebas
meas esse aliquid putare nugas,
iam tum cum ausus es unus Italorum
omne aevum tribus explicare chartis
doctis, Iuppiter, et laboriosis....
A quick spot of Catullus #WorldBookDay
“cui dono lepidum novum libellum
arido modo pumice expolitum?
Corneli, tibi: namque tu solebas
meas esse aliquid putare nugas,
iam tum cum ausus es unus Italorum
omne aevum tribus explicare chartis
doctis, Iuppiter, et laboriosis....
De doctis nihil nisi optime!
July 13, 2026 at 11:12 AM
De doctis nihil nisi optime!
Doctis fortuna favet et turpe nescire. Although it’s doubtless more to do with the folly of affluent parents.
January 3, 2025 at 5:18 PM
Doctis fortuna favet et turpe nescire. Although it’s doubtless more to do with the folly of affluent parents.
Great to see the DoCTIS Atlas on therapeutic drug response across IMIDs presented at #ACR2025! 🧬
Built in the EU project doctis.eu
, this work earned an Excellence in Research Award and now feeds into DarkMatter - Congratulations Toni Julià!
— AI for immune prediction.
#AI4Health #IMIDs
Built in the EU project doctis.eu
, this work earned an Excellence in Research Award and now feeds into DarkMatter - Congratulations Toni Julià!
— AI for immune prediction.
#AI4Health #IMIDs
October 27, 2025 at 10:00 AM
Great to see the DoCTIS Atlas on therapeutic drug response across IMIDs presented at #ACR2025! 🧬
Built in the EU project doctis.eu
, this work earned an Excellence in Research Award and now feeds into DarkMatter - Congratulations Toni Julià!
— AI for immune prediction.
#AI4Health #IMIDs
Built in the EU project doctis.eu
, this work earned an Excellence in Research Award and now feeds into DarkMatter - Congratulations Toni Julià!
— AI for immune prediction.
#AI4Health #IMIDs
🌟 Back from #EULAR2025 inspired!
🏅 Antonio Juliá wins Abstract Award for single-cell insights (DoCTIS)
🎤 Diane van der Woude on predicting RA before symptoms
🔬 DarkMatter’s mission—early detection & stratification—gains momentum.
#PrecisionMedicine #Autoimmunity
🏅 Antonio Juliá wins Abstract Award for single-cell insights (DoCTIS)
🎤 Diane van der Woude on predicting RA before symptoms
🔬 DarkMatter’s mission—early detection & stratification—gains momentum.
#PrecisionMedicine #Autoimmunity
June 20, 2025 at 7:04 AM
🌟 Back from #EULAR2025 inspired!
🏅 Antonio Juliá wins Abstract Award for single-cell insights (DoCTIS)
🎤 Diane van der Woude on predicting RA before symptoms
🔬 DarkMatter’s mission—early detection & stratification—gains momentum.
#PrecisionMedicine #Autoimmunity
🏅 Antonio Juliá wins Abstract Award for single-cell insights (DoCTIS)
🎤 Diane van der Woude on predicting RA before symptoms
🔬 DarkMatter’s mission—early detection & stratification—gains momentum.
#PrecisionMedicine #Autoimmunity
Big congrats to Antonio Julià (Vall d'Hebron) for winning the EULAR 2025 Abstract Award! 🏆 His DoCTIS study maps molecular variation across 6 IMIDs via single-cell RNAseq — paving the way for precision medicine! 👏 Talk: June 13, 10:30 CEST #EULAR2025 #DarkMatter
June 12, 2025 at 6:32 AM
Big congrats to Antonio Julià (Vall d'Hebron) for winning the EULAR 2025 Abstract Award! 🏆 His DoCTIS study maps molecular variation across 6 IMIDs via single-cell RNAseq — paving the way for precision medicine! 👏 Talk: June 13, 10:30 CEST #EULAR2025 #DarkMatter
Today I conducted a tutorial with two students entirely in Latin, discussing the character of Aeneas in Virgil’s Aeneid.
An exhilarating experience.
scholam hodie habui cum duobus discipulis doctis omnino Latine de ingenio et Aeneae in Aeneide Vergilii disputantibus.
Res animum valde calefecit.
An exhilarating experience.
scholam hodie habui cum duobus discipulis doctis omnino Latine de ingenio et Aeneae in Aeneide Vergilii disputantibus.
Res animum valde calefecit.
January 29, 2025 at 5:44 PM
Today I conducted a tutorial with two students entirely in Latin, discussing the character of Aeneas in Virgil’s Aeneid.
An exhilarating experience.
scholam hodie habui cum duobus discipulis doctis omnino Latine de ingenio et Aeneae in Aeneide Vergilii disputantibus.
Res animum valde calefecit.
An exhilarating experience.
scholam hodie habui cum duobus discipulis doctis omnino Latine de ingenio et Aeneae in Aeneide Vergilii disputantibus.
Res animum valde calefecit.
Disce, sed a doctis, indoctos ipse doceto :)
July 27, 2025 at 8:29 AM
Disce, sed a doctis, indoctos ipse doceto :)